Evaluating the impact of self‐monitoring of blood glucose frequencies on glucose control in patients with type 2 diabetes who do not use insulin: A systematic review and meta‐analysis
- 29 April 2019
- journal article
- research article
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 73 (7) , e13357
Abstract
Aims International diabetes guidelines have not established the frequencies of self‐monitoring of blood glucose in patients with type 2 diabetes (T2D) who do not use insulin. The present study aimed to assess the impact of SMBG frequencies on the glucose control and other outcomes in non‐insulin‐treated patients with T2D. Methods A literature search was performed in four databases. Randomised controlled trials with ≥ 6‐month follow‐up duration that compared the impact of different frequencies of SMBG on glycated haemoglobin A1c (HbA1c) were included. Studies with abstract only or reported effects of SMBG as a secondary outcome were excluded. Results Of the 1,557 studies identified, 12 RCTs with a total of 3,350 patients were analyzed. Overall, performing SMBG for 8 to 14 times per week was correlated with a better HbA1c control at six months (MD ‐0.46%, 95% CI ‐0.54 to ‐0.39) and 12 months (MD ‐0.20%, 95% CI ‐0.29 to ‐0.11). However, up to seven measurements of SMBG per week did not significantly affect glycemic control. In addition, performing SMBG between 8 and 14 times per week was also associated with improved BMI (MD ‐0.46, 95% CI ‐0.84 to ‐0.08). When the results of SMBG were applied to adjust diabetes medication, a significant reduction in HbA1c levels was observed in the intervention arm compared to the control arm. Conclusions 8 to 14 measurements of SMBG per week were associated with an improved glycemic control and a reduced BMI in patients with T2D not using insulin.Keywords
This publication has 40 references indexed in Scilit:
- Perspectives of patients with type 1 or insulin-treated type 2 diabetes on self-monitoring of blood glucose: a qualitative studyBMC Public Health, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- GRADE guidelines: 3. Rating the quality of evidenceJournal of Clinical Epidemiology, 2011
- GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tablesJournal of Clinical Epidemiology, 2011
- Self-monitoring of blood glucose in non-insulin treated patients with type 2 diabetes: a systematic review and meta-analysisCurrent Medical Research and Opinion, 2009
- The efficacy of self‐monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release–based regimen. A multicentre, randomized, parallel‐group, 6‐month evaluation (DINAMIC 1 study)Diabetes, Obesity and Metabolism, 2008
- Effect of the Frequency of Self-Monitoring Blood Glucose in Patients with Type 2 Diabetes Treated with Oral Antidiabetic Drugs—A Multi-Centre, Randomized Controlled TrialPLOS ONE, 2008
- Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trialBMJ, 2008
- Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trialBMJ, 2007
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998